Skip to main content
Year archive

J.B. Chemicals & Pharmaceuticals Lt — 2022 filings

All 181 regulatory filings released by J.B. Chemicals & Pharmaceuticals Lt (JBCHEPHARM) in 2022, sourced directly from the official regulator.

181 Filings
2022 Period
2022 filings (181)
Filing Released Lang
Trading Window
Regulatory Filings
2022-12-30 English
Closure of Trading Window
Regulatory Filings
2022-12-30 English
Copy of Newspaper Publication
Regulatory Filings
2022-12-28 English
Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).
Regulatory Filings
2022-12-28 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas, acting through its Hong Kong branch
Regulatory Filings
2022-12-23 English
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for BNP Paribas, acting through its Hong Kong Branch
Regulatory Filings
2022-12-23 English
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December ....
Major Shareholding Notification
2022-12-23 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 22, 2022 for Tau Investment Holdings ....
Major Shareholding Notification
2022-12-23 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 22, 2022 for Tau Investment Holdings ....
Major Shareholding Notification
2022-12-23 English
Updates
Capital/Financing Update
2022-12-21 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
M&A Activity
2022-12-21 English
ESOP/ESOS/ESPS
Share Issue/Capital Change
2022-12-20 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2022-12-20 English
Press Release
Capital/Financing Update
2022-12-14 English
Press Release
Capital/Financing Update
2022-12-14 English
General updates
Capital/Financing Update
2022-12-14 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Capital/Financing Update
2022-12-14 English
Closure of trading window
Regulatory Filings
2022-12-09 English
Closure of Trading Window
Regulatory Filings
2022-12-09 English
General updates
Regulatory Filings
2022-11-30 English
JB Chemicals & Pharmaceuticals Limited (JB Pharma) receives ANDA approval for Venlafaxine Hydrochloride Extended-Release Tablets from USFDA.
Regulatory Filings
2022-11-30 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-11-18 English
Enclosed please find Transcript of Conference Call which was scheduled for Investors and Analysts on November 14, 2022 at 3.30 p.m. IST in relation to results and developments for the second ....
Call Transcript
2022-11-18 English
General updates
Share Issue/Capital Change
2022-11-17 English
Compensation Committee of the Board of Directors of the Company has, on November 17, 2022, allotted 18,730 fully paid up equity shares of Rs. 2/- each of the Company, to certain employees ....
Share Issue/Capital Change
2022-11-17 English
Related Party Transaction
Audit Report / Information
2022-11-16 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-11-14 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/analysts ....
Regulatory Filings
2022-11-14 English
Newspaper Advertisements
Regulatory Filings
2022-11-12 English
Newspaper cutting of extract of consolidated financial results for quarter ended on September 30, 2022
Regulatory Filings
2022-11-12 English
Issue of duplicate share certificate
Share Issue/Capital Change
2022-11-11 English
Loss of share certificate
Regulatory Filings
2022-11-11 English
Investor Presentation
Investor Presentation
2022-11-11 English
investors/analysts presentation the Company proposes to on performance of the Company for the quarter ended on September 30, 2022.
Investor Presentation
2022-11-11 English
Press Release
Earnings Release
2022-11-11 English
Enclosed please find press release the Company proposes to issue on unaudited consolidated financial results for the quarter ended on September 30, 2022.
Earnings Release
2022-11-11 English
Outcome of Board Meeting
Regulatory Filings
2022-11-11 English
In compliance with Regulation 30(2) and Regulation 33(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with circular ....
Regulatory Filings
2022-11-11 English
Investors/ Analysts call with Management
Call Transcript
2022-11-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-11-05 English
Board Meeting — Financial results
Regulatory Filings
2022-11-03 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 ,inter alia, to consider and approve unaudited ....
Regulatory Filings
2022-11-03 English
Press Release
Environmental & Social Information
2022-10-13 English
Press Release
Environmental & Social Information
2022-10-13 English
Submission of Sustainability Report for the financial year 2021-22
Environmental & Social Information
2022-10-13 English
Business Responsibility & Sustainability Report (BRSR)
Environmental & Social Information
2022-10-13 English
General updates
Regulatory Filings
2022-10-11 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2022-10-11 English
Closure of trading window
Regulatory Filings
2022-09-30 English
Closure of Trading Window
Regulatory Filings
2022-09-30 English
Loss of share certificate
Regulatory Filings
2022-09-28 English
Intimation of loss of share certificate
Regulatory Filings
2022-09-28 English
Loss of share certificate
Regulatory Filings
2022-09-27 English
Intimation of loss of share certificate
Regulatory Filings
2022-09-27 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2022-09-13 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-09-13 English
Transcript of 46th Annual General Meeting
Call Transcript
2022-09-08 English
General updates
Call Transcript
2022-09-08 English
Result of Voting at Annual General Meeting
Regulatory Filings
2022-08-25 English
Annual General Meeting
Regulatory Filings
2022-08-25 English
Proceedings of the Annual General Meeting
Regulatory Filings
2022-08-24 English
Annual General Meeting
Regulatory Filings
2022-08-24 English
Allotment of Equity Shares on exercise of Stock options pursuant to Employee Stock Option Scheme
Share Issue/Capital Change
2022-08-20 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change
2022-08-20 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-09 English
Transcript of Investors/Analysts call
Regulatory Filings
2022-08-09 English
Loss of share certificate
Regulatory Filings
2022-08-09 English
Intimation of loss of share certificate
Regulatory Filings
2022-08-09 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/Analysts ....
Regulatory Filings
2022-08-05 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-08-05 English
Newspaper cutting of extract of consolidated financial results for the quarter ended on June 30, 2022
Regulatory Filings
2022-08-05 English
Newspaper Advertisements
Regulatory Filings
2022-08-05 English
Disclosure under Regulation 30 of Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015 read with the Securities and Exchange Board ....
Regulatory Filings
2022-08-04 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-08-04 English
Investor Presentation
Regulatory Filings
2022-08-04 English
Press Release
Regulatory Filings
2022-08-04 English
Investor Presentation
Interim / Quarterly Report
2022-08-04 English
Press Release on unaudited consolidated financial results for the quarter ended on June 30, 2022.
Regulatory Filings
2022-08-04 English
Outcome of Board Meeting
Regulatory Filings
2022-08-04 English
Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended June 30, 2022
Regulatory Filings
2022-08-04 English
Investors/analysts call with management
Call Transcript
2022-07-29 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Call Transcript
2022-07-29 English
Newspaper Advertisements
Regulatory Filings
2022-07-29 English
Newspaper advertisement
Regulatory Filings
2022-07-29 English
Record Date
Regulatory Filings
2022-07-29 English
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2022-07-29 English
Annual Report for the year 2021-22
Regulatory Filings
2022-07-28 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-28 English
Annual General Meeting
Regulatory Filings
2022-07-28 English
Board Meeting — Financial results
Regulatory Filings
2022-07-26 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2022 ,inter alia, to consider and approve unaudited ....
Regulatory Filings
2022-07-26 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-07-21 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-07-21 English
Certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018
Regulatory Filings
2022-07-12 English
General updates
Regulatory Filings
2022-07-12 English
Newspaper Advertisements
Regulatory Filings
2022-07-05 English
Prior Public Notice for Equity Shareholders of the Company with regard to convening of AGM through Video Conferencing (VC)/Other Audio Visual Means (OAVM).
Regulatory Filings
2022-07-05 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-06-30 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-06-30 English
Closure of trading window
Regulatory Filings
2022-06-28 English
Closure of Trading Window
Regulatory Filings
2022-06-28 English
Related Party Transaction
Regulatory Filings
2022-06-09 English
Disclosure of related party transactions for second half of the financial year 2021-22
Regulatory Filings
2022-06-09 English
Newspaper Advertisements
Regulatory Filings
2022-06-03 English
Newspaper advertisement in respect of transfer of equity shares of the Company to Investor Education and Protection Fund (IEPF).
Regulatory Filings
2022-06-03 English
Intimation of loss of share certificate
Regulatory Filings
2022-06-03 English
Loss of share certificate
Major Shareholding Notification
2022-06-03 English
Disclosure under regulation 30 of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-06-01 English
General updates
Regulatory Filings
2022-06-01 English
Transcript of Investors/Analysts Meet
Regulatory Filings
2022-05-31 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-31 English
Recording of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings
2022-05-28 English
Disclosure under regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Audio recording of Investors/Analysts Meet
Regulatory Filings
2022-05-28 English
Newspaper Advertisements
Regulatory Filings
2022-05-27 English
Newspaper cutting of extract of consolidated financial results for quarter and year ended on March 31, 2022
Regulatory Filings
2022-05-27 English
Investor Presentation
Regulatory Filings
2022-05-27 English
Investor presentation on financial results for the quarter and year ended on March 31, 2022.
Regulatory Filings
2022-05-27 English
Financial Result Updates
Regulatory Filings
2022-05-26 English
Press release the Company on audited consolidated financial results for the quarter and year ended on March 31, 2022.
Regulatory Filings
2022-05-26 English
Press Release
Regulatory Filings
2022-05-26 English
Dividend
Notice of Dividend Amount
2022-05-26 English
Outcome of Board Meeting
Regulatory Filings
2022-05-26 English
Recommendation of final dividend of Rs. 8 per share of FV Rs. 2 (400%) for FY 2021-22.
Notice of Dividend Amount
2022-05-26 English
1. Audited standalone financial results for the year ended on March 31, 2022 accompanied by Auditors' Report. 2. Audited consolidated financial results for the year ended on March ....
Regulatory Filings
2022-05-26 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation
2022-05-20 English
Investors/Analysts Meet with management- May 27, 2022 at 3.30 p.m. IST in relation to business performance for Q4 & FY22 and other strategic imperatives.
Regulatory Filings
2022-05-20 English
Annual Secretarial Compliance Report for the financial year ended on March 31, 2022.
Regulatory Filings
2022-05-13 English
JB Chemicals & Pharmaceuticals Ltd has informed BSE that meeting of the Board of Director of the Company will be held on May 26, 2022, inter alia, to consider and approve:1. Audited ....
Regulatory Filings
2022-05-11 English
Intimation of Board Meeting
Regulatory Filings
2022-05-11 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2022 ,inter alia, to consider and approve (i) audited ....
Regulatory Filings
2022-05-11 English
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings
2022-04-28 English
General updates
Regulatory Filings
2022-04-28 English
Certificate under Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for financial year 2021-22
Regulatory Filings
2022-04-20 English
Compliance certificate under regulation 7(3) for the year ended March 31, 2022
Regulatory Filings
2022-04-14 English
Loss of share certificate
Regulatory Filings
2022-04-13 English
Issue of duplicate share certificate
Regulatory Filings
2022-04-13 English
Issue of duplicate share certificate.
Regulatory Filings
2022-04-13 English
Loss of share certificate
Regulatory Filings
2022-04-13 English
Update on Assignment of Trademark for Azmarda® indicated for heart failure patients with reduced ejection fraction (HfrEF) from Novartis AG, Switzerland for India
Regulatory Filings
2022-04-12 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-04-12 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-04-01 English
Disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2022-04-01 English
Closure of trading window
Regulatory Filings
2022-03-31 English
Closure of Trading Window
Regulatory Filings
2022-03-31 English
Resignation of Director
Board/Management Information
2022-03-12 English
Resignation
Board/Management Information
2022-03-12 English
Earnings conference call Transcript and Audio recording
Regulatory Filings
2022-02-18 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-02-18 English
Newspaper cutting of extract of consolidated financial results for quarter ended on December 31, 2021
Regulatory Filings
2022-02-15 English
Copy of Newspaper Publication
Regulatory Filings
2022-02-15 English
Record Date
Notice of Dividend Amount
2022-02-14 English
Investor Presentation
Regulatory Filings
2022-02-14 English
Press Release
Regulatory Filings
2022-02-14 English
Investor Presentation
Regulatory Filings
2022-02-14 English
Press Release
Regulatory Filings
2022-02-14 English
Intimation of Record Date pursuant to Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Regulatory Filings
2022-02-14 English
Financial Result Updates
Regulatory Filings
2022-02-14 English
Dividend
Regulatory Filings
2022-02-14 English
Outcome of meeting of Board of Directors-Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), 2015 read with circular CIR/CFD/CMD/4/2015 dated September ....
Regulatory Filings
2022-02-14 English
Outcome of Board Meeting
Regulatory Filings
2022-02-14 English
Outcome of meeting of Board of Directors - Unaudited Financial Results for the quarter ended December 31, 2021
Regulatory Filings
2022-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-02-08 English
Investors/analysts call with management
Regulatory Filings
2022-02-08 English
J.B.CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve (i) unaudited ....
Regulatory Filings
2022-02-07 English
Board Meeting — Financial Results/Dividend
Regulatory Filings
2022-02-07 English
Intimation of loss of share certificate
Regulatory Filings
2022-02-03 English
Loss of Share Certificates
Regulatory Filings
2022-02-03 English
Acquisition
Capital/Financing Update
2022-02-01 English
Update on Acquisition of Brands and Related Assets from Sanzyme Private Limited
Regulatory Filings
2022-02-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-31 English
Investors/analysts call Transcript and Audio recording
Regulatory Filings
2022-01-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-27 English
Investor Presentation -in relation to the Acquisition of Brands and Related Assets from Sanzyme Private Limited.
Regulatory Filings
2022-01-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-26 English
The Company has scheduled a conference call for investors and analysts on Thursday, January 27, 2022 at 3.30 p.m. IST to discuss the Acquisition of Brands and Related Assets from Sanzyme ....
Regulatory Filings
2022-01-26 English
Press Release
Regulatory Filings
2022-01-26 English
Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited
Regulatory Filings
2022-01-26 English
Resignation of Director
Regulatory Filings
2022-01-26 English
Press Release
Regulatory Filings
2022-01-26 English
Acquisition
Regulatory Filings
2022-01-26 English
Change in Director(s)
Regulatory Filings
2022-01-26 English